Free Case Review

Disclaimer

The Strength of HHK

  • Over $35 Billion Recovered.
  • Over 70 Years Of Experience.
  • Leading The Fight Against BP.
  • Cutting Edge Courtroom Presentations.
  • No Recovery. No Fee.

Recent Victories

Brain Injury

$24,227,916

Burn Injury

$10,000,000

Offshore Maritime

$1,500,000

Client Testimonials


Granuflo and Naturalyte

New Orleans, LA Granuflo and Naturalyte Claims Lawyers

Herman Herman & Katz is investigating potential lawsuits on behalf of dialysis patients who suffered serious heart related injuries from using Fresenius’ Granuflo or NaturaLyte products.  

Granuflo and NaturaLyte dialysis products.

Woman Suffering Chest PainGranuflo and NaturaLyte are chemical products used in dialysis machines to help clean the blood of patients with kidney impairment. These ingredients are intended to prevent the buildup of dangerous acids that are naturally removed in people whose kidneys function normally. Recent information has come to light, however, that these products may also increase patients’ risk of having heart attack or other serious cardiovascular problems.

Fresenius Medical Care, the maker of Granuflo and NaturaLyte, is one of the largest dialysis product manufacturers in the world. Fresenius owns a majority share in the multiple billion dollar dialysis market and operates dozens of dialysis centers across the country, providing dialysis for over 100,000 people in the US alone.

According to a recent New York Times article, the FDA is now investigating whether Fresenius violated federal regulations in failing to inform patients and doctors of a potentially lethal risk connected to its products. The New York Times has discovered that Fresenius’s medical office sent an internal memo to doctors working in its own dialysis centers to warn that the use of their products could potentially be fatal. However, Fresenius failed to warn other dialysis centers using its products of the same risk until after the FDA received an anonymous copy of the internal memo.

Granuflo and NaturaLyte recall by the FDA:

On March 29, 2012, the U.S. Food and Drug Administration (FDA) issued a recall of GranuFlo and NaturaLyte, stating that the use of these products can result in dangerously high levels of bicarbonate, which can cause metabolic alkalosis – a condition associated with low blood pressure, cardiac arrhythmia, heart attack, cardiac arrest, and other cardiovascular problems.

It is unclear how many dialysis patients have been injured as a result of Fresenius’s failure to warn of the risks associated with their dialysis products. GranuFlo and NaturaLyte are still being used in dialysis clinics to this day and have not been recalled. Fresenius has even applied to the FDA for approval a new dialysis solution that does not contain the substance linked to cardiovascular injury.

We can provide legal help for your Granuflo claims.

Many patients across the country have suffered serious heart related injuries from using Fresenius’s dialysis products. 

  • Heart attack
  • Sudden cardiac death
  • Cardiopulmonary arrest
  • Cardiovascular death
  • Stroke

If you believe you have suffered any of the above injuries after receiving dialysis treatment, learn about your legal rights from an experienced Louisiana class action lawyer by calling 504-581-4892 or by filling out our free, no obligation case review form.



Herman Herman & Katz, LLC
820 O'Keefe Ave
New Orleans, LA 70113
Phone: (504) 581-4892

Copyright ©2017 Herman Herman & Katz, L.L.C.

Leave a Reply

Your email address will not be published. Required fields are marked *